Aug 162016
 

By Talent4Boards Team

Talent4Boards – Great Talent builds Great Boards

– USA, MD – REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy based on its proprietary NAV Technology Platform, today announced the appointment of Daniel Tassé to its board of directors, effective August 15, 2016.… => Read more

REGENXBIO appointed Daniel Tasse to the Board of Directors

From:: REGENXBIO appointed Daniel Tasse to the Board of Directors

 Posted by at 1:00 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: